New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
The validations confirm the completion of the applications and commence the scientific review process
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
CuraTeQ Biologics is on track for filing a second oncology biosimilar
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
The conclave brought together key stakeholders from across the assisted living ecosystem
The trial will enroll up to 42 patients in Finland across four cohorts
Subscribe To Our Newsletter & Stay Updated
